Zoster (Shingles)

Clinical Resources

Materials for Providers

Alphabetical by Title

Standing Orders for Administering Recombinant Zoster Vaccine to Adults

Eligible healthcare professionals may vaccinate adults who meet any of the criteria on this form

Materials for Vaccine Recipients

Alphabetical by Title

Shingles (Zoster): Questions and Answers

Information about the disease and vaccines for patients

View all Clinical Resources

CDC · FDA · State

ACIP Recommendations

Current Recommendations

ACIP Recommendations for Use of Recombinant Zoster Vaccine (RZV, Shingrix, GSK) in Immunocompromised Adults aged 19 years and older, US, 2022
MMWR, January 21, 2022, 71(3);80-84
Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines
MMWR, January 26, 2018; 67(3); 103–108
Prevention of Herpes Zoster: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
MMWR, June 6, 2008; 57(05):1-30

Vaccine Information Statements

Zoster, Recombinant VIS
Updated: February 4, 2022

FDA Package Inserts & EUAs

Zoster (shingles): Shingrix Package Insert
GSK

More from Immunize.org

Unprotected People Stories

This page was updated on .